the Insulin Resistance in Recurrent Miscarriage IN RECURRENT ABORTION

Recurrent Abortion Clinical Trial

Official title:

Insulin Resistance and Recurrent Abortion

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT02088424
• Other study ID #: mohd-1978
• Status: Not yet recruiting
• Phase: N/A
• First received: March 8, 2014
• Last updated: March 13, 2014
• Start date: March 2014
• Est. completion date: April 2015

Study information

• Verified date: March 2014
• Source: Ain Shams University
• Contact: mohamed a selem, master
• Phone: 00201116724786
• Email: drghost_3000[@]yahoo.com
• Is FDA regulated: No
• Health authority: United States: Institutional Review Board
• Study type: Observational [Patient Registry]

Clinical Trial Summary

THE INSULIN RESISTANCE IN RECURRENT ABORTION

Description:

THE ROLE OF INSULIN RESISTANCE IN RECURRENT ABORTION

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 30
• Est. completion date: April 2015
• Est. primary completion date: November 2014
• Accepts healthy volunteers: No
• Gender: Female
• Age group: 23 Years to 40 Years

Eligibility

Inclusion Criteria:

1. Women in the child bearing period between 23-40 years.

2. All patients are pregnant.

3. The gestational age of both groups 6-13 weeks

Exclusion Criteria:

1. Patients with gestational diabetes and gestational impaired glucose tolerance.

2. The patients who took medication that could affect glucose metabolism at the time of the study

3. Patients with other causes of recurrent abortion as(thyroid dysfunction, uterine anomalies chromosomal abnormalities, antiphspholipid antibody syndrome, uterine anomalies and TORCH syndrome).

4. Patients with PCOS.

5. Obese patients(BMI>30)

Study Design

Observational Model: Case Control, Time Perspective: Cross-Sectional

Related Conditions & MeSH terms

• Abortion, Habitual
• Insulin Resistance
• Recurrent Abortion

Intervention

Other:
• insulin resistance(fasting glucose/fasting insulin)
insulin resistance(fasting glucose/fasting insulin )

Locations

Country	Name	City	State
Egypt	Ain shams maternity hospital	Cairo

Sponsors (1)

Lead Sponsor	Collaborator
Ain Shams University

Country where clinical trial is conducted

Egypt, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Other	oral glucose tolerance test		3 month	No
Primary	fasting blood glucose	Click here for more information about this study: the role of insulin resistance in recurrent abortion	3 month	No
Secondary	fasting Insulin		3 month	No